Phoenix ED device is the first at-home use acoustic wave device that helps in the treatment of erectile dysfunction. The ...

AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced that it will present a preclinical ...

Roche already has a significant existing US presence with more than 25,000 employees, 15 R&D centres and 13 manufacturing sites ...

The active ingredient in Lipozem has been the subject of conflicting research findings. Read this review to see whether these ...

Zevra Continues Growth Trajectory into a Global Commercial Rare Disease Company with Consistent Execution, New Product ...

The new THCa products were developed to meet growing demand for federally legal, high-purity cannabis alternatives. Boston ...

GenF20 Plus is a supplement made with amino acids, peptides and nutrients that help the pituitary gland function better and ...

Often dubbed the “Steve Jobs of medical labs,” El-Hosseiny is no stranger to innovation—or controversy. As the inventor of a revolutionary safety lancet and the holder of a U.S. patent for a novel ...

HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in gastric cancer ...

Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today reported that it received notice from the ...

This growing awareness has led to explosive growth in the gut health supplement market projected to reach $17.4 billion as of ...

The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcasts will be ...